Overexpression of GATA-3 in T cells accelerates dextran sulfate sodium-induced colitis

Experimental Animals

Volumn 63, Issue 2, 2014, Pages 133-140

  Okamura, Midori ^a   Yoh, Keigyou ^a   Ojima, Masami ^a   Morito, Naoki ^a   Takahashi, Satoru ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Dextran sulfate sodium; GATA 3; IL 13; Inflammatory bowel disease; T helper cell

Indexed keywords

HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; TRANSCRIPTION FACTOR GATA 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL INFILTRATION; CLINICAL DISEASE ACTIVITY INDEX; CONTROLLED STUDY; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; FLUORESCENCE MICROSCOPY; GENE OVEREXPRESSION; HELPER CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; COLITIS, ULCERATIVE; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION; INTERLEUKIN-13; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; TH1 CELLS; TH17 CELLS; TH2 CELLS;

EID: 84899424860     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.63.133     Document Type: Article

References (32)

1. Alex, P., Zachos, N.C., Nguyen, T., Gonzales, L., Chen, T.E., Conklin, L.S., Centola, M., and Li, X. 2009. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm. Bowel Dis. 15: 341-352. [Medline] [CrossRef]
2. Bento, A.F., Leite, D.F., Marcon, R., Claudino, R.F., Dutra, R.C., Cola, M., Martini, A.C., and Calixto, J.B. 2012. Evaluation of chemical mediators and cellular response during acute and chronic gut inflammatory response induced by dextran sodium sulfate in mice. Biochem. Pharmacol. 84: 1459-1469. [Medline] [CrossRef]
3. Brown, J.B., Cheresh, P., Zhang, Z., Ryu, H., Managlia, E., and Barrett, T.A. 2012. P-selectin glycoprotein ligand-1 is needed for sequential recruitment of T-helper 1 (Th1) and local generation of Th17 T cells in dextran sodium sulfate (DSS) colitis. Inflamm. Bowel Dis. 18: 323-332. [Medline] [CrossRef]
4. Danese, S. and Fiocchi, C. 2011. Ulcerative colitis. N. Engl. J. Med. 365: 1713-1725. [Medline] [CrossRef]
5. Egger, B., Bajaj-Elliott, M., MacDonald, T.T., Inglin, R., Eysselein, V.E., and Buchler, M.W. 2000. Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion 62: 240-248. [Medline] [CrossRef]
6. Farrar, J.D., Asnagli, H., and Murphy, K.M. 2002. T helper subset development: roles of instruction, selection, and transcription. J. Clin. Invest. 109: 431-435. [Medline]
7. Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T., and Fujiyama, Y. 2003. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52: 65-70. [Medline] [CrossRef]
8. Fuss, I.J., Heller, F., Boirivant, M., Leon, F., Yoshida, M., Fichtner-Feigl, S., Yang, Z., Exley, M., Kitani, A., Blumberg, R.S., Mannon, P., and Strober, W. 2004. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J. Clin. Invest. 113: 1490-1497. [Medline]
9. Harrington, L.E., Hatton, R.D., Mangan, P.R., Turner, H., Murphy, T.L., Murphy, K.M., and Weaver, C.T. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6: 1123-1132. [Medline] [CrossRef]
10. Heller, F., Florian, P., Bojarski, C., Richter, J., Christ, M., Hillenbrand, B., Mankertz, J., Gitter, A.H., Burgel, N., Fromm, M., Zeitz, M., Fuss, I., Strober, W., and Schulzke, J.D. 2005. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129: 550-564. [Medline]
11. Hundorfean, G., Neurath, M.F., and Mudter, J. 2012. Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease. Inflamm. Bowel Dis. 18: 180-186. [Medline] [CrossRef]
12. Ishizaki, K., Yamada, A., Yoh, K., Nakano, T., Shimohata, H., Maeda, A., Fujioka, Y., Morito, N., Kawachi, Y., Shibuya, K., Otsuka, F., Shibuya, A., and Takahashi, S. 2007. Th1 and type 1 cytotoxic T cells dominate responses in T-bet overexpression transgenic mice that develop contact dermatitis. J. Immunol. 178: 605-612. [Medline]
13. Ito, R., Kita, M., Shin-Ya, M., Kishida, T., Urano, A., Takada, R., Sakagami, J., Imanishi, J., Iwakura, Y., Okanoue, T., Yoshikawa, T., Kataoka, K., and Mazda, O. 2008. Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. Biochem. Biophys. Res. Commun. 377: 12-16. [Medline] [CrossRef]
14. Ivanov, I.I., McKenzie, B.S., Zhou, L., Tadokoro, C.E., Lepelley, A., Lafaille, J.J., Cua, D.J., and Littman, D.R. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121-1133. [Medline] [CrossRef]
15. Kawada, M., Arihiro, A., and Mizoguchi, E. 2007. Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease. World J. Gastroenterol. 13: 5581-5593. [Medline]
16. Kim, T.W., Park, H.J., Choi, E.Y., and Jung, K.C. 2006. Overexpression of CIITA in T cells aggravates Th2-mediated colitis in mice. J. Korean Med. Sci. 21: 877-882. [Medline] [CrossRef]
17. Lim, B.O. 2004. Efficacy of wogonin in the production of immunoglobulins and cytokines by mesenteric lymph node lymphocytes in mouse colitis induced with dextran sulfate sodium. Biosci. Biotechnol. Biochem. 68: 2505-2511. [Medline] [CrossRef]
18. Neurath, M.F., Finotto, S., and Glimcher, L.H. 2002. The role of Th1/Th2 polarization in mucosal immunity. Nat. Med. 8: 567-573. [Medline] [CrossRef]
19. Okayasu, I., Hatakeyama, S., Yamada, M., Ohkusa, T., Inagaki, Y., and Nakaya, R. 1990. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98: 694-702. [Medline]
20. Park, H., Li, Z., Yang, X.O., Chang, S.H., Nurieva, R., Wang, Y.H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., and Dong, C. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141. [Medline] [CrossRef]
21. Perse, M. and Cerar, A. 2012. Dextran sodium sulphate colitis mouse model: traps and tricks. J. Biomed. Biotechnol. 2012: 718617. [Medline] [CrossRef]
22. Podolsky, D.K. 2002. Inflammatory bowel disease. N. Engl. J. Med. 347: 417-429. [Medline] [CrossRef]
23. Sanada, Y., Mizushima, T., Kai, Y., Nishimura, J., Hagiya, H., Kurata, H., Mizuno, H., Uejima, E., and Ito, T. 2011. Therapeutic effects of novel sphingosine-1-phosphate receptor agonist W-061 in murine DSS colitis. PLoS ONE 6: e23933. [Medline] [CrossRef]
24. Strober, W. and Fuss, I.J. 2011. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140: 1756-1767. [Medline] [CrossRef]
25. Szabo, S.J., Kim, S.T., Costa, G.L., Zhang, X., Fathman, C.G., and Glimcher, L.H. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655-669. [Medline] [CrossRef]
26. Vatn, M.H. 2009. Natural history and complications of IBD. Curr. Gastroenterol. Rep. 11: 481-487. [Medline] [CrossRef]
27. Wilson, N.J., Boniface, K., Chan, J.R., McKenzie, B.S., Blumenschein, W.M., Mattson, J.D., Basham, B., Smith, K., Chen, T., Morel, F., Lecron, J.C., Kastelein, R.A., Cua, D.J., McClanahan, T.K., Bowman, E.P., and de Waal Malefyt, R. 2007. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8: 950-957. [Medline] [CrossRef]
28. Yoh, K., Morito, N., Ojima, M., Shibuya, K., Yamashita, Y., Morishima, Y., Ishii, Y., Kusakabe, M., Nishikii, H., Fujita, A., Matsunaga, E., Okamura, M., Hamada, M., Suto, A., Nakajima, H., Shibuya, A., Yamagata, K., and Takahashi, S. 2012. Overexpression of RORgammat under control of the CD2 promoter induces polyclonal plasmacytosis and autoantibody production in transgenic mice. Eur. J. Immunol. 42: 1999-2009. [Medline] [CrossRef]
29. Yoh, K., Shibuya, K., Morito, N., Nakano, T., Ishizaki, K., Shimohata, H., Nose, M., Izui, S., Shibuya, A., Koyama, A., Engel, J.D., Yamamoto, M., and Takahashi, S. 2003. Transgenic overexpression of GATA-3 in T lymphocytes improves autoimmune glomerulonephritis in mice with a BXSB/MpJYaa genetic background. J. Am. Soc Nephrol. 14: 2494-2502. [Medline] [CrossRef]
30. Zhang, D.H., Cohn, L., Ray, P., Bottomly, K., and Ray, A. 1997. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J. Biol. Chem. 272: 21597-21603. [Medline] [CrossRef]
31. Zheng, W. and Flavell, R.A. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89: 587-596. [Medline] [CrossRef]
32. Zhumabekov, T., Corbella, P., Tolaini, M., and Kioussis, D. 1995. Improved version of a human CD2 minigene based vector for T cell-specific expression in transgenic mice. J. Immunol. Methods 185: 133-140. [Medline] [CrossRef]